Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,147,502
+$750,380 QoQ
Shares Held
282,510
-1.7% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. ACAD ranks #41 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,147,502 | 282,510 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,397,122 | 287,382 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $8,396,314 | 314,351 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $7,143,798 | 334,761 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,149,979 | 331,478 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,408,547 | 325,620 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,441,320 | 133,042 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,913,685 | 124,427 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,978,322 | 121,743 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,247,385 | 121,546 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $3,627,200 | 115,848 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,406,894 | 115,494 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,752,333 | 114,920 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,204,423 | 117,132 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,766,116 | 110,937 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,826,626 | 111,652 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,651,347 | 117,200 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,899,109 | 119,699 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,418,350 | 103,614 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,781,554 | 107,258 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,015,759 | 82,647 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $3,408,179 | 132,100 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,137,390 | 133,509 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,051,581 | 146,705 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,129,597 | 147,093 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,299,640 | 78,098 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||